Healthcare -
Biotechnology - NASDAQ - US
$ 22.04
-0.136 %
$ 3.74 B
Market Cap
-9.97
P/E
IMVT - RESEARCH & DEVELOPMENT
Research & Development IMVT - Immunovant, Inc.
213 M
LAST VALUE
44.62%
2 YEAR CAGR
52.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR